Russell Investments Group, Ltd.
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1692234
Seattle, WA
Position in TAK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,447,428
+$48,200 QoQ
Shares Held
152,678
+17.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 376 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. TAK ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in TAK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,447,428 | 152,678 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,399,228 | 129,548 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,558,719 | 99,982 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,394,694 | 95,266 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,284,123 | 83,061 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $958,564 | 64,463 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $600,089 | 45,324 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $433,610 | 30,493 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $225,893 | 17,457 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $148,289 | 10,676 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $92,227 | 6,463 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $116,365 | 7,522 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $126,434 | 8,048 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $115,920 | 7,034 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,654,567 | 106,062 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,375,624 | 106,062 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $5,902,065 | 420,375 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $5,284,266 | 369,013 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $5,192,593 | 380,968 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $6,117,979 | 373,503 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $3,671,498 | 218,152 | Shares | Defined | 2021-08-04 | |
| 2020-06-30 | $289,103 | 16,124 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||